Publication

Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic burkitt lymphoma

Oduor, Cliff I.
Chelimo, Kiprotich
Ouma, Collins
Mulama, David H.
Foley, Joslyn
Vulule, John M.
Bailey, Jeffrey A.
Moormann, Ann M.
Embargo Expiration Date
Abstract

Overexpression of interleukin-6 (IL-6) and IL-10 in endemic Burkitt lymphoma (eBL) may facilitate tumorigenesis by providing a permissive cytokine milieu. Promoter polymorphisms influence interindividual differences in cytokine production. We hypothesized that children genetically predisposed for elevated cytokine levels may be more susceptible to eBL. Using case-control samples from western Kenya consisting of 117 eBL cases and 88 ethnically matched healthy controls, we tested for the association between eBL risk and IL-10 (rs1800896, rs1800871, and rs1800872) and IL-6 (rs1800795) promoter single nucleotide polymorphisms (SNPs) as well as IL-10 promoter haplotypes. In addition, the association between these variants and Epstein Barr Virus (EBV) load was examined. Results showed that selected IL-10 and IL-6 promoter SNPs and IL-10 promoter haplotypes were not associated with risk eBL or EBV levels in EBV-seropositive children. Findings from this study reveal that common variants within the IL-10 and IL-6 promoters do not independently increase eBL risk in this vulnerable population.

Source

Am J Trop Med Hyg. 2014 Sep 3;91(3):649-54. doi: 10.4269/ajtmh.13-0616. Epub 2014 Jul 28. Link to article on publisher's site

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.4269/ajtmh.13-0616
PubMed ID
25071000
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Distribution License